Nov 16 (Reuters) - NLS Pharmaceutics AG NLSP.O :
* NLS PHARMACEUTICS AG - ANNOUNCES SELECTION OF STRATEGIC
PARTNER
AND SECURING A BRIDGE LOAN
* NLS PHARMACEUTICS AG - ANNOUNCES SELECTION OF STRATEGIC
PARTNER
AND SECURING A BRIDGE LOAN
* NLS PHARMACEUTICS AG - EXECUTED A NON-BINDING TERM SHEET
FOR
LICENSING OF NLS INTELLECTUAL PROPERTY
* NLS PHARMACEUTICS AG - EXECUTED A NON-BINDING TERM SHEET
FOR
LICENSING OF NLS INTELLECTUAL PROPERTY
* NLS PHARMACEUTICS AG - IMPLEMENTED SIGNIFICANT INTERNAL
COST
REDUCTIONS
* NLS PHARMACEUTICS AG - IMPLEMENTED SIGNIFICANT INTERNAL
COST
REDUCTIONS
* NLS PHARMACEUTICS AG - SECURED AN ADDITIONAL BRIDGE LOAN
THROUGH
INSIDERS TO EXTEND CASH RUNWAY
* NLS PHARMACEUTICS AG - SECURED AN ADDITIONAL BRIDGE LOAN
THROUGH
INSIDERS TO EXTEND CASH RUNWAY
* NLS PHARMACEUTICS AG - CONDUCTING AN ONGOING PROCESS TO
EXPLORE
STRATEGIC ALTERNATIVES
* NLS PHARMACEUTICS AG - CONDUCTING AN ONGOING PROCESS TO
EXPLORE
STRATEGIC ALTERNATIVES
* NLS PHARMACEUTICS AG - IMPLEMENTED A WORKFORCE REDUCTION
OF
APPROXIMATELY 50%
* NLS PHARMACEUTICS AG - IMPLEMENTED A WORKFORCE REDUCTION
OF
APPROXIMATELY 50%
* NLS PHARMACEUTICS - REDUCTION INCLUDES PAUSE ON CONSULTING
AGREEMENTS, REDUCTION IN NON-CLINICAL STAFF, REDUCTION IN
NON-ESSTENTIAL OPERATING EXPENSES
* NLS PHARMACEUTICS - REDUCTION INCLUDES PAUSE ON CONSULTING
AGREEMENTS, REDUCTION IN NON-CLINICAL STAFF, REDUCTION IN
NON-ESSTENTIAL OPERATING EXPENSES
Source text for Eikon: ID:
Further company coverage: NLSP.O
((Reuters.Briefs@thomsonreuters.com;))